Kalaris Therapeutics (KLRS) Misses Q2 EPS by 61c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. QCOM
6. ACN
7. AZN
8. ROIV
9. AAPL
10. HOOD

Go back to Kalaris Therapeutics (KLRS) Misses Q2 EPS by 61c
(NASDAQ: KLRS) Delayed: 3.63 -0.27 (6.92%)
Previous Close $3.90    52 Week High $ 
Open $3.88    52 Week Low $ 
Day High $3.90    P/E N/A 
Day Low $3.60    EPS $ 
Volume 100,720